This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Merck + Co., Inc.. Active years: 1987-1993.
Location History:
- Los Angeles, CA (US) (1987)
- Seattle, WA (US) (1992 - 1993)
Company Filing History:
2 out of 4,770 
Years Active: 1987-1993
Title: David B. Finkelstein: Innovator in Biochemical Engineering
Introduction
David B. Finkelstein is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biochemical engineering, particularly in the development of processes related to cephalosporin antibiotics. With a total of 3 patents to his name, Finkelstein's work has had a meaningful impact on pharmaceutical advancements.
Latest Patents
Finkelstein's latest patents include innovative processes for the conversion of cephalosporin C and its derivatives. One of his key patents involves a gene encoding a one-step cephalosporin C amidase and its expression. This process allows for the efficient conversion of cephalosporin C to 7-aminocephalosporanic acid, utilizing a specific enzyme and DNA sequence in a suitable host, such as Bacillus species.
Career Highlights
Finkelstein is currently employed at Merck & Co., Inc., where he continues to advance his research in the pharmaceutical industry. His work focuses on improving antibiotic production methods, which are crucial for addressing bacterial infections.
Collaborations
Throughout his career, Finkelstein has collaborated with esteemed colleagues, including John A. Rambosek and Mark S. Crawford. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
David B. Finkelstein is a prominent figure in the field of biochemical engineering, with a focus on antibiotic development. His patents and ongoing work at Merck & Co., Inc. reflect his commitment to advancing pharmaceutical science.